Can I read Fibroadenoma Cryoablation Market Insights on EtoBox?

Fibroadenoma Cryoablation Market Insights by yoni63 is a document available to read on EtoBox.

What is Fibroadenoma Cryoablation Market Insights about?

IceCure specializes in treating low-risk early-stage breast cancer in women over 60 using cryoablation, a non-surgical method that freezes tumors to induce cell death. The procedure has shown a low recurrence rate of 2.06% and high patient satisfaction, with 95% reporting cosmetic satisfaction. IceCure has received regulatory approvals in 15 countries and is seeking FDA approval for its ProSense® device, aiming for market availability by 2025.

Author

yoni63

Language

EN